Press Releases
Cell Press highlights the work of Philochem’s industrial Ph.D student
We are delighted to share the exciting journey of one of our talented PhD students Sara Puglioli, which has recently been covered in a CHEM article (Cell Press). Over the...
Read morePhilogen publishes a new study in Pharmaceutics
Philogen announces the publication of a study in the peer-reviewed journal “Pharmaceutics” describing the development and the in vitro/vivo characterization of a novel interferon-gamma (IFNg) based antibody fusion protein. The paper...
Read moreUpcoming Events
Philogen to attend 19th EADO Congress on April 20-22, 2023
Dr. Covelli (CMO), Dr. Elia, Dr. Ravenni, and Dr. Nadal will participate at the event in Rome. The dermato-oncology team from St. Gallen will give a presentation entitled “Intralesional administration...
Read morePhilogen to attend the 19th PEGSBOSTON in Boston, on May 15-19, 2023
Prof. Dr. Dario Neri (CEO and CSO), is giving a KEYNOTE presentation on the 18th of May 2023 entitled “Antibody-Cytokine Fusions for the Treatment of Difficult-to-Cure Cancer Types: Emerging Clinical...
Read morePhilogen to attend the Lund Spring Symposium in Lund on May 22-24, 2023
Prof. Dr. Dario Neri (CEO and CSO) is participating as a speaker at Lund Spring Symposium.
Follow the link for more details.
Past Events
Philogen to attend Mediobanca 5th MidCap Conference on January 18, 2023 in Milan
Philogen announces its attendance at the 5th MidCap Conference organised by Mediobanca. Prof. Dario Neri (CEO and CSO), Laura Baldi (CFO), and Emanuele Puca (Investor Relations) will participate at the event....
Read morePhilogen to attend the 13th World ADC conference in London on the 13th and 14th of March, 2023
Philogen announces its attendance at World ADC2023 in London. Dr. Samuele Cazzamalli (Head of Small Molecule Therapeutics at Philochem) is giving a lecture on the 14th of March 2023 entitled “Enhancing the Therapeutic...
Read morePhilogen to attend the Antibody Engineering & Therapeutics on December 4-8, 2022 in San Diego
Philogen announces its attendance at the Antibody Engineering & Therapeutics 2022. Prof. Dario Neri, CEO and CSO of Philogen, is giving a lecture entitled “Small Molecule-drug Conjugates (SMDCs) and Antibody-drug Conjugates (ADCs):...
Read more